JSPR Stock Summary and Trading Ideas (Jasper Therapeutics - Class A | NASDAQ:JSPR)

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Jasper Therapeutics - Class A trades on the NASDAQ stock market under the symbol JSPR.

As of March 31, 2026, JSPR stock price declined to $0.88 with 639,147 million shares trading.

JSPR has a beta of 2.32, meaning it tends to be more sensitive to market movements. JSPR has a correlation of 0.16 to the broad based SPY ETF.

JSPR has a market cap of $24.52 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, JSPR traded as high as $31.01 and as low as $.81.

The top ETF exchange traded funds that JSPR belongs to (by Net Assets): VTI, VXF, IWC.

JSPR has underperformed the market in the last year with a price return of -80.4% while the SPY ETF gained +18.4%. JSPR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -51.1% and -29.3%, respectively, while the SPY returned -5.1% and -2.5%, respectively.

JSPR support price is $.86 and resistance is $.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that JSPR shares will trade within this expected range on the day.